Impact of Overactive Bladder Step Therapy Policies on Medication Utilization and Expenditures Among Treated Medicare Members.

Abbass, Ibrahim M; Caplan, Eleanor O; Ng, Daniel B; Kristy, Rita; Schermer, Carol R; Bradt, Pamela; Collins, Jenna M; Chan, Wai Man Maria; Suehs, Brandon T

Abbass, Ibrahim M; Caplan, Eleanor O; Ng, Daniel B; Kristy, Rita; Schermer, Carol R; Bradt, Pamela; Collins, Jenna M; Chan, Wai Man Maria; Suehs, Brandon T.

Affiliation

Abbass IM; 1 Comprehensive Health Insights, Louisville, Kentucky.
Caplan EO; 1 Comprehensive Health Insights, Louisville, Kentucky.
Ng DB; 2 Astellas Pharma Global Development, Northbrook, Illinois.
Kristy R; 2 Astellas Pharma Global Development, Northbrook, Illinois.
Schermer CR; 2 Astellas Pharma Global Development, Northbrook, Illinois.
Bradt P; 2 Astellas Pharma Global Development, Northbrook, Illinois.
Collins JM; 1 Comprehensive Health Insights, Louisville, Kentucky.
Chan WM; 3 Humana Pharmacy Solutions, Louisville, Kentucky.
Suehs BT; 1 Comprehensive Health Insights, Louisville, Kentucky.

J Manag Care Spec Pharm ; 23(1): 27-37, 2017 Jan.

Article de En | MEDLINE | ID: mdl-28025920

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Dépenses de santé / Utilisation médicament / Vessie hyperactive / Agents urologiques Type d'étude: Health_economic_evaluation / Observational_studies / Prevalence_studies / Risk_factors_studies Limites: Aged / Female / Humans / Male Pays/Région comme sujet: America do norte Langue: En Journal: J Manag Care Spec Pharm Année: 2017 Type de document: Article

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google